Michael Rosenblatt

Michael Rosenblatt

Director/Board Member bei PYC THERAPEUTICS LIMITED

Vermögen: 786 172 $ am 31.03.2024

76 Jahre
Health Technology
Health Services
Consumer Services

Profil

Michael A.
Rosenblatt
is the founder of Theracrine, Inc. (founded in 2006) and Radius Health, Inc. (founded in 2003).
He is currently an Independent Director at Azenta, Inc. (since 2018), a Non-Executive Director at PYC Therapeutics Ltd.
(since 2021), a Director at Ferring Pharmaceuticals, Inc. (since 2016), a Non-Executive Director at Perspectum Ltd., a Director at Ohana Biosciences, Inc. (since 2016), a Director at Cygnal Therapeutics, Inc. (since 2016), a Director at Cobalt Biomedicine, Inc. (since 2016), a Director at Perspectum Group Ltd., a Senior Advisor at Flagship Pioneering, and an Advisor at Puretech Health LLC.
He has held former positions as a Non-Executive Director at Shire Plc (2008-2008, 2008-2009), a Director at ProScript, Inc., a Director at Project HOPE-The-People-To-People Health Foundation, Inc., a Director at Harvard Mit Health Sciences & Technology (1992-1998), an Independent Director at Axcella Health, Inc. (2022-2023), an Independent Director at Rubius Therapeutics, Inc. (2014-2023), the Chief Medical Officer & Executive Vice President at Merck & Co., Inc. (1984-2016), the Chief Medical Officer at Schering-Plough Corp., a Principal at The General Hospital Corp.
(1981-1984), a Senior Vice President-Academic Programs at CareGroup, Inc. (1996-2000), the President at Beth Israel Deaconess Medical Center, Inc. (1996-2003), a Member-Scientific Counselors Board at the National Institute of Diabetes & Digestive & Kidney Diseases, a Senior Vice President-Research at Merck Research Laboratories Massachusetts LLC, a Professor at Harvard Medical School, and a Senior Vice President-Research at Merck Sharp & Dohme Corp.
(1984-1992).
He also served as a Professor at Molecular Medicine LLC and as the Dean at Tufts University School of Medicine.
Dr. Rosenblatt obtained his undergraduate degree from The Trustees of Columbia University in The City of New York and his doctorate degree from Harvard Medical School.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
12.02.2024 13 042 ( 0,02% ) 786 172 $ 31.03.2024
31.10.2023 0 ( -.--% ) - $ 31.12.2023
30.06.2023 0 ( -.--% ) - $ 31.03.2024

Aktive Positionen von Michael Rosenblatt

UnternehmenPositionBeginn
AZENTA, INC. Director/Board Member 05.09.2018
PYC THERAPEUTICS LIMITED Director/Board Member 17.03.2021
Director/Board Member 25.02.2022
Director/Board Member -
Director/Board Member 01.01.2016
Consultant / Advisor 01.01.2022
Director/Board Member 01.01.2016
Director/Board Member 01.01.2016
Corporate Officer/Principal 29.12.2010
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
Alle aktiven Positionen von Michael Rosenblatt

Ehemalige bekannte Positionen von Michael Rosenblatt

UnternehmenPositionEnde
░░░░ ░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░ ░░░░ ░░░░ ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░ ░░░ ░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Michael Rosenblatt im Detail an

Ausbildung von Michael Rosenblatt

The Trustees of Columbia University in The City of New York Undergraduate Degree
Harvard Medical School Doctorate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Michael Rosenblatt im Detail an

Beziehungen

100 +

Beziehungen ersten Grades

31

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen3
MERCK & CO., INC.

Health Technology

AZENTA, INC.

Health Services

AXCA HEALPAR

Health Technology

Private Unternehmen24

Health Technology

Commercial Services

Health Technology

Health Technology

Health Services

Finance

Health Technology

PYC Therapeutics Ltd.

Finance

Commercial Services

Health Services

Health Technology

Health Services

National Institute of Diabetes & Digestive & Kidney Diseases

Government

Health Technology

Health Technology

Health Technology

Health Services

Molecular Medicine LLC

Health Technology

Commercial Services

Health Technology

Health Technology

Technology Services

Sehen Sie sich die Unternehmensverbindungen an
  1. Börse
  2. Insiders
  3. Michael Rosenblatt